首页> 外文期刊>Cancer Biology >Aloe-emodin Induces Apoptosis through the Up-Regulation of Fas in the Human Breast Cancer Cell Line MCF-7
【24h】

Aloe-emodin Induces Apoptosis through the Up-Regulation of Fas in the Human Breast Cancer Cell Line MCF-7

机译:芦荟大黄素通过上调人类乳腺癌细胞系MCF-7 Fas诱导凋亡。

获取原文
           

摘要

Aloe-emodin is a Hydroxyanthraquinone that exists in Aloe Vera leaves and has been known to have anti-tumor effects. Various studies have mentioned the biologic effects of Aloe Vera such as antiviral, antimicrobial and some hepato-protective effects. Recently its antitumor effects have attracted many researchers. Breast cancer is the most common malignancy in women, accounting for 30% of all female cancers and 1% of all cancer cases in men. Breast cancer also is responsible for 15% of cancer deaths in women. The aim of the present study was to investigate the anti-cancer effect of aloe-emodin on human breast cancer MCF-7 cell line. Materials and Methods: MCF-7cells were cultured in RPMI medium with 10 % fetal bovine serum (FBS) . The cytotoxic effect of different concentrations (5, 10, 25, 50, and 100 μM) of Aloe-emodin on cultured cells were evaluated by MTT assay at different times (24, 48, 72 h). Apoptosis and CD95 (Fas) expression were analyzed by flow-cytometry using an Annexin V-FITC/PI kit and Fas (CD95) kit according to the manufacturer’s protocol. Results: Aloe-emodin decreases the viability of MCF-7 cell line in a time and dose dependent manner, so that the most effective concentration of this substance was 100μM and 72h after treatment. According to the data of Fas (CD95) expression and Annexin-PI, the highest apoptosis induction rate was seen in 100μM and 72 h. Conclusion: The findings of the present study indicated that Aloe-emodin has some antitumor effects and can be used in the treatment of breast cancer. However, further investigation of its cytotoxic effects against tumor cells, both in vitro and in vivo, is recommended.
机译:芦荟大黄素是一种存在于芦荟叶中的羟基蒽醌,已知具有抗肿瘤作用。各种研究都提到了芦荟的生物作用,例如抗病毒,抗微生物和某些肝保护作用。最近,它的抗肿瘤作用吸引了许多研究人员。乳腺癌是女性中最常见的恶性肿瘤,占所有女性癌症的30%,占男性所有癌症病例的<1%。乳腺癌也是造成女性癌症死亡人数15%的原因。本研究的目的是研究芦荟大黄素对人乳腺癌MCF-7细胞系的抗癌作用。材料和方法:MCF-7细胞在含10%胎牛血清(FBS)的RPMI培养基中培养。通过MTT分析在不同时间(24、48、72小时)评估不同浓度(5、10、25、50和100μM)的芦荟大黄素对培养细胞的细胞毒性作用。根据制造商的规程,使用Annexin V-FITC / PI试剂盒和Fas(CD95)试剂盒通过流式细胞仪分析细胞凋亡和CD95(Fas)表达。结果:芦荟大黄素以时间和剂量依赖性方式降低MCF-7细胞的活力,因此该物质的最有效浓度为100μM,治疗后72h。根据Fas(CD95)表达和Annexin-PI的数据,在100μM和72 h时凋亡诱导率最高。结论:本研究结果表明芦荟大黄素具有一定的抗肿瘤作用,可用于乳腺癌的治疗。但是,建议进一步研究其在体外和体内对肿瘤细胞的细胞毒性作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号